NCT03041792View on ClinicalTrials.gov

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

January 16, 2018

Study Completion Date

January 16, 2018

Conditions

Obesity

Interventions

DRUG

Liraglutide

Liraglutide

OTHER

Placebo

Placebo

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT03041792 - Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects | Biotech Hunter | Biotech Hunter